Patients with rheumatoid arthritis (RA) have higher rates of mortality attributed to the inflammatory nature and the associated burden of cardiovascular complications. Previous research indicates that treatment with statin therapy may play a role in reducing the mortality rate of RA patients, but similar evidence in U.S. patients is lacking.
AMCP and AMCP Foundation have set forth a four-part research agenda that identifies and prioritizes critical evidentiary gaps in managed care pharmacy.
A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.
A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.
A cost impact analysis of Medicare patients with Alzheimer's disease and dementia in their final years of life found that families and Medicaid bear the bear most of the cost burden. The authors of this JMCP article propose the need to better integrate Medicare and Medicaid to fund and improve patient outcomes.